Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: Influence of neutrophils

Pharmacological Research

Volumn 56, Issue 2, 2007, Pages 168-174

  Gonzalez Correa J A ^a   Munoz Marin J ^a   Lopez Villodres J A ^a   Navas, M D ^a   Guerrero, A ^a   Torres, J A ^a   De La Cruz, J P ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Acetylsalicylic acid; Cyclooxygenase; Nitric oxide; Salicylic acid

Indexed keywords

ACETYLSALICYLIC ACID; NITRIC OXIDE; SALICYLIC ACID; THROMBOXANE B2;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; IC 50; IN VITRO STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SYNTHESIS; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADULT; ASPIRIN; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; MALE; NEUTROPHILS; NITRIC OXIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; SALICYLIC ACID; THROMBOXANE B2;

EID: 34548119885     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.05.006     Document Type: Article

References (32)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 324 (2002) 71-86
2. Ferguson J.J. The role of oral antiplatelet agents in atherothrombotic disease. Am J Cardiovasc Drugs 6 (2006) 149-157
3. Patrono C., Garcia-Rodriguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 (2005) 2373-2383
4. Marcus A.J. Aspirin and thromboembolism-a possible dilemma. N Engl J Med 297 (1977) 1284-1285
5. de Gaetano G., Cerletti C., Dejana E., and Latini R. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation 72 (1985) 1185-1193
6. Pedersen A.K., and FitzGerald G.A. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N Engl J Med 311 (1984) 1206-1211
7. FitzGerald G.A., Lupinetti M., Charman S.A., and Charman W.N. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2. J Pharmacol Exp Ther 259 (1991) 1043-1049
8. Clarke R.J., Mayo G., Price P., and FitzGerald G.A. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 325 (1991) 1137-1141
9. De La Cruz J.P., Guerrero A., Gonzalez-Correa J.A., Marquez E., Nacle I., and Sanchez de la Cuesta F. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans. Eur J Clin Pharmacol 57 (2002) 775-780
10. De La Cruz J.P., Gonzalez-Correa J.A., Guerrero A., Marquez E., Martos F., and Sanchez De La Cuesta F. Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers. Fund Clin Pharmacol 17 (2003) 363-372
11. Zhang X. Real time and in vivo monitoring of nitric oxide by electrochemical sensors-from dream to reality. Front Biosci 9 (2004) 3434-3446
12. Cerletti C., Bonati M., del Maschio A., Galletti F., Dejana E., Tognoni G., et al. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. J Lab Clin Med 103 (1984) 869-877
13. Merino J., Livio M., Rajtar G., and de Gaetano G. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation. Biochem Pharmacol 29 (1980) 1093-1096
14. Rotilio D., Joseph D., Hatmi M., and Vargaftig B.B. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites. Eur J Pharmacol 97 (1984) 197-208
15. Vargaftig B.B. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol 50 (1978) 231-241
16. Peterson D.A., Gerrard J.M., Rao G.H., and White J.G. Salicylic acid inhibition of the irreversible effect of acetylsalicylic acid on prostaglandin synthetase may be due to competition for the enzyme cationic binding site. Prostaglandins Med 6 (1981) 161-164
17. Cerletti C., Gambino M.C., Garattini S., and de Gaetano G. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels. J Clin Invest 78 (1986) 323-326
18. Dejana E., Cerletti C., de Castellarnau C., Livio M., Galletti F., Latini R., et al. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. J Clin Invest 68 (1981) 1108-1112
19. Gambino M.C., Passaghe S., Chen Z.M., Bucchi F., Gori G., Latini R., et al. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats. J Pharmacol Exp Ther 245 (1988) 287-290
20. De La Cruz J.P., Blanco E., and Sanchez de la Cuesta F. Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 397 (2000) 35-41
21. Lopez-Farre A., Caramelo C., Esteban A., Alberola M.L., Millas I., Monton M., et al. Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 91 (1995) 2080-2088
22. De La Cruz J.P., Bellido I., Camara S., Martos F., and Sanchez de la Cuesta F. Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: an in vitro study. Scand J Haematol 36 (1986) 394-397
23. De La Cruz J.P., Camara S., Bellido I., Carrasco T., and Sanchez de la Cuesta F. Platelet aggregation in human whole blood after chronic administration of aspirin. Thromb Res 46 (1987) 133-140
24. Gonzalez-Correa J.A., Arrebola M.M., Guerrero A., Cañada M.J., Muñoz-Marin J., Sanchez De la Cuesta F., et al. Antioxidant and antiplatelet effects of the alpha-tocopherol-aspirin combination in type 1-like diabetic rats. Life Sci 79 (2006) 1405-1412
25. Taubert D., Berkels R., Grosser N., Schroder H., Grundemann D., and Schomig E. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol 143 (2004) 159-165
26. Salvemini D., de Nucci G., Gryglewski R.J., and Vane R.J. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA 86 (1989) 6328-6332
27. de Frutos T., Sánchez de Miguel L., Farré J., Gómez J., Romero J., Marcos-Alberca P., et al. Expression of an endotelial type nitric oxide synthase isoform in human neutrophils: modification by tumor necrosis factor-alpha and during acute myocardial infarction. J Am Coll Cardiol 37 (2001) 800-807
28. Sánchez de Miguel L., Arriero M.M., Farré J., Jiménez P., garcía-Mendez A., de Frutos T., et al. Nitric oxide production by neutrophils obtained from patients during acute coronary síndromes: expresión of the nitric oxide synthase isoforms. J Am Coll Cardiol 39 (2002) 818-825
29. Läfars G., and Gyllenhammar H. Stimulus-dependent transduction mechanisms for nitric oxide release in human polymorphonuclear neutrophil leucocytes. J Lab Clin Med 132 (1998) 54-60
30. Carreras M.C., Pargament G.A., Catz S.D., Poderoso J.J., and Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett 341 (1994) 65-68
31. Guerrero A., Gonzalez-Correa J.A., Arrebola M.M., Muñoz-Marin J., Sanchez de la Cuesta F., and de la Cruz J.P. Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect. Neurosci Lett 358 (2004) 153-156
32. De La Cruz J.P., Guerrero A., Gonzalez-Correa J.A., Arrebola M.M., and Sánchez de la Cuesta F. Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia. J Neurosci Res 75 (2004) 280-290